title: Malignant rhabdoid tumor presenting as a hemangioma.
abstract: Malignant rhabdoid tumor is a rare and highly aggressive malignancy of unknown etiology. We report a primary cutaneous rhabdoid tumor on the upper back of a newborn. It was initially diagnosed as a hemangioma clinically, and that diagnosis was supported by radiologic studies, including magnetic resonance imaging. However, detailed investigation with light microscopy, immunohistochemistry, and electron microscopy enabled us to make a diagnosis of rhabdoid tumor. This is the seventh reported case of rhabdoid tumor with primary cutaneous involvement.
authors.affiliation: Department of Dermatology, University of Texas, Houston Medical School, USA.
authors.forename: A E
authors.initials: AE
authors.lastname: Albregts
authors.forename: A A
authors.initials: AA
authors.lastname: Hebert
authors.forename: R A
authors.initials: RA
authors.lastname: Aboul-Nasr
authors.forename: R B
authors.initials: RB
authors.lastname: Raney
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D003609:Dactinomycin / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D017809:Fatal Outcome; D005260:Female; D006391:Hemangioma / Q000175:diagnosis* / Q000628:therapy; D006801:Humans; D007223:Infant; D012074:Remission Induction; D018335:Rhabdoid Tumor / Q000175:diagnosis* / Q000628:therapy; D012782:Shoulder; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D003609:Dactinomycin; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide